Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.34 |
| ▸ | CA4 | P22748 | 1/20 | 0.34 |
| ▸ | CA6 | P23280 | 1/20 | 0.34 |
| ▸ | CA7 | P43166 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10980180 | 0.84 | ALDH1A1 (0.38) | ALDH1A1ALOX15CYP2C19MAPTHDAC8 | |
| SCHEMBL1618931 | 0.83 | TSHR (0.44) | APEX1 | |
| SCHEMBL11372036 | 0.83 | TSHR (0.44) | APEX1 | |
| Phthalic Acid SCHEMBL368309 | 0.79 | ALDH1A1 (0.50) | ALDH1A1ALOX15CYP2C19MAPTHDAC8 | |
| Oxirane SCHEMBL10479243 | 0.76 | GABRR1 (0.38) | APEX1 | |
| Phthalic Acid SCHEMBL9331101 | 0.73 | ALDH1A1 (0.61) | ALDH1A1ALOX15MAPTHDAC8KMT2A | |
| Phthalic Acid SCHEMBL28724935 | 0.72 | ALDH1A1 (0.67) | ALDH1A1ALOX15MAPTHDAC8AKR1C3 | |
| Phthalic Acid SCHEMBL33468 | 0.72 | ALDH1A1 (0.74) | ALDH1A1ALOX15MAPTHDAC8AKR1C3 | |
| Phthalic Acid SCHEMBL33470 | 0.72 | ALDH1A1 (0.74) | ALDH1A1ALOX15MAPTHDAC8AKR1C3 | |
| Phthalic Acid SCHEMBL9241582 | 0.72 | ALDH1A1 (0.54) | ALDH1A1ALOX15MAPTHDAC8KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0153105-B1 | DIFFUSION COATED MULTIPLE-UNITS DOSAGE FORM | BENZON PHARMA A/S (DK) | 1992-09-09 | — | — | EP | claimed |
| EP-0153105-A2 | Diffusion coated multiple-units dosage form | BENZON PHARMA A/S (DK) | 1985-08-28 | — | — | EP | claimed |
| EP-0153104-A2 | Diffusion coated multiple-units dosage form | BENZON PHARMA A/S (DK) | 1985-08-28 | — | — | EP | claimed |
| WO-1985003437-A1 | DIFFUSION COATED MULTIPLE-UNITS DOSAGE FORM | A/S ALFRED BENZON (DK) | 1985-08-15 | — | — | WO | claimed |
| US-7070803-B2 | Controlled release pharmaceutical composition for oral use containing midodrine and/or active metabolite, desglymidodrine | NYCOMED AUSTRIA GMBH (AT) | 2006-07-04 | — | — | US | disclosed |
| EP-1267841-B1 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING MIDODRINE AND/OR DESGLYMIDODRINE | NYCOMED AUSTRIA GMBH (AT) | 2004-11-24 | — | — | EP | disclosed |
| US-6761904-B2 | CONTROLLED RELEASE FOR FAST PEAK PLASMA CONCENTRATION OF THE ACTIVE METABOLITE DESGLYMIDODRINE; TREATING ORTHOSTAIC HYPOTENSION AND/OR URINARY INCONTINENCE | NYCOMED AUSTRIA GMBH (AT) | 2004-07-13 | — | — | US | disclosed |
| EP-1017370-B1 | MODIFIED RELEASE MULTIPLE-UNITS COMPOSITIONS OF NON-STEROID ANTI-INFLAMMATORY DRUG SUBSTANCES (NSAIDs) | NYCOMED DANMARK APS (DK) | 2003-10-29 | — | — | EP | disclosed |
| EP-0888111-B1 | MODIFIED RELEASE MULTIPLE-UNITS DOSAGE COMPOSITION | NYCOMED DANMARK AS (DK) | 2003-05-21 | — | — | EP | disclosed |
| EP-1289493-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING DESGLYMIDODRINE AS AN ACTIVE DRUG SUBSTANCE | Nycomed Austria GmbH (AT) | 2003-03-12 | — | — | EP | disclosed |
| EP-1282406-A1 | PHARMACEUTICAL KIT COMPRISING MIDODRINE AS AN ACTIVE DRUG SUBSTANCE | Nycomed Austria GmbH (AT) | 2003-02-12 | — | — | EP | disclosed |
| EP-1267841-A1 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING MIDODRINE AND/OR DESGLYMIDODRINE | Nycomed Austria GmbH (AT) | 2003-01-02 | — | — | EP | disclosed |
| EP-0153104-B1 | DIFFUSION COATED MULTIPLE-UNITS DOSAGE FORM | BENZON PHARMA A/S (DK) | 1993-04-21 | — | — | EP | disclosed |
| EP-0153105-B1 | DIFFUSION COATED MULTIPLE-UNITS DOSAGE FORM | BENZON PHARMA A/S (DK) | 1992-09-09 | — | — | EP | disclosed |
| US-4716041-A | SUSTAINED RELEASE | A/S ALFRED BENZON (DK) | 1987-12-29 | — | — | US | disclosed |
| US-4713248-A | MIXTURE OF FILM FORMING AGENT WITH COMPRESSIBLE POLYMER | A/S ALFRED BENZON (DK) | 1987-12-15 | — | — | US | disclosed |
| EP-0153105-A2 | Diffusion coated multiple-units dosage form | BENZON PHARMA A/S (DK) | 1985-08-28 | — | — | EP | disclosed |
| EP-0153104-A2 | Diffusion coated multiple-units dosage form | BENZON PHARMA A/S (DK) | 1985-08-28 | — | — | EP | disclosed |
| WO-1985003436-A1 | DIFFUSION COATED MULTIPLE-UNITS DOSAGE FORM | A/S ALFRED BENZON (DK) | 1985-08-15 | — | — | WO | disclosed |
| WO-1985003437-A1 | DIFFUSION COATED MULTIPLE-UNITS DOSAGE FORM | A/S ALFRED BENZON (DK) | 1985-08-15 | — | — | WO | disclosed |